The Merck Co-pay Assistance Program offers assistance to eligible patients who need help affording ZINPLAVA. Once enrolled, eligible, privately insured patients pay the first $100 of their co-pay. Maximum Co-pay Assistance Program benefit applies. See Terms and Conditions. Co-pay assistance from the Merck Co-pay Assistance Program is not insurance.
Full Answer
What is the Zinplava co-pay assistance program?
The Merck Co-pay Assistance Program offers assistance to eligible, privately insured patients who need help affording the out-of-pocket costs for ZINPLAVA. Once enrolled, eligible, privately insured patients pay the first $100 of their co-pay.
What is Zinplava used to treat?
ZINPLAVA is a human monoclonal antibody that binds to Clostridium difficile toxin B indicated to reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older who are receiving antibacterial drug treatment of CDI and are at high risk for CDI recurrence. ZINPLAVA is not indicated for the treatment of CDI.
When should Zinplava be used to treat congestive heart failure (CHF)?
In patients with a history of congestive heart failure (CHF), ZINPLAVA should be used when the benefit outweighs the risk. Heart failure was reported more commonly in the two Phase 3 clinical trials in ZINPLAVA-treated patients compared to placebo-treated patients.
How do I find a Zinplava infusion center?
Help patients and health care providers looking for ZINPLAVA infusion centers by signing up to submit your information for possible inclusion in the ZINPLAVA Infusion Center Locator (ZICL). The ZICL will allow patients and health care providers to search for infusion centers administering ZINPLAVA within a geographic location.